Bio-Rad
Bio-Rad Laboratories Q1 Revenues Shrink 4 Percent, Firm Lowers Full-Year Guidance
The firm said the decline in revenues was primarily due to lower net sales in its life science business, though its clinical diagnostics sales also fell.
Vendors, kit makers, and service providers using dPCR are crafting diverse strategies to ramp up adoption of the technology.
Top Five Articles on 360Dx Last Week: Blood-Based Testing in Neurology; End of NHS England; More
Last week, readers were most interested in a story about how blood-based testing is making increasing inroads for neurological conditions.
Bio-Rad Receives IVDR Certification for Infectious Disease Molecular Quality Controls
The firm's CT/NG Positive Run Control and STI Negative Run Control will be the first products CE-marked under IVDR.
Digital PCR's Clinical Push Could be Accelerated by Bio-Rad Acquisition of Stilla Technologies
Premium
Will the acquisition finally lead to an accelerated adoption of digital PCR in the clinical space?
Mar 3, 2025
360Dx Top 30 Drops 9 Percent in February
Feb 14, 2025
Nov 1, 2024
360Dx Top 30 Falls 3 Percent in October
May 1, 2024
360Dx Top 30 Falls 6 Percent in April
Sep 25, 2023